目的 探討原發性甲狀旁腺功能亢進癥(PHPT)的診治經驗。
方法 回顧性分析我院近15年間18例手術治療的PHPT患者的臨床資料。
結果 初診病例術前核素99Tcm-sestamibi掃描和B超檢查陽性定位診斷率分別為100%(9/9)和88%(15/17)。18例均經手術治療,其中1例為再手術病例。術后病理診斷甲狀旁腺腺瘤13例,其中1例為雙腺瘤; 甲狀旁腺增生4例; 甲狀旁腺腺癌1例。首次手術治愈率為88%(15/17)。2例甲狀旁腺增生病例未治愈。再手術1例因損傷了單側喉返神經致術后聲音嘶啞。
結論 術前核素99Tcm-sestamibi掃描和B超檢查對制定手術方案有重要意義,大多數PHPT病例適合行單側頸部探查術。甲狀旁腺增生病例的手術治愈率低。
引用本文:
解乃昌,林進令,陸云飛. 18例原發性甲狀旁腺功能亢進癥的診治分析. 中國普外基礎與臨床雜志, 2007, 14(1): 87-88. doi:
復制
1. |
AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism [J]. Endocr Pract, 2005; 11(1)∶49.
|
2. |
Inabnet WB. Intraoperative parathyroid hormone monitoring [J]. World J Surg, 2004; 28(12)∶1212.
|
3. |
Parikshak M, Castillo ED, Conrad MF, et al. Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for priary hyperparathyroidism [J]. Am Surg, 2003; 69(5)∶393.
|
- 1. AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism [J]. Endocr Pract, 2005; 11(1)∶49.
- 2. Inabnet WB. Intraoperative parathyroid hormone monitoring [J]. World J Surg, 2004; 28(12)∶1212.
- 3. Parikshak M, Castillo ED, Conrad MF, et al. Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for priary hyperparathyroidism [J]. Am Surg, 2003; 69(5)∶393.